1. Home
  2. CMTL vs CTSO Comparison

CMTL vs CTSO Comparison

Compare CMTL & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

HOLD

Current Price

$4.67

Market Cap

162.1M

Sector

Technology

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.72

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMTL
CTSO
Founded
1967
1997
Country
United States
United States
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.1M
45.7M
IPO Year
2024
2008

Fundamental Metrics

Financial Performance
Metric
CMTL
CTSO
Price
$4.67
$0.72
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.00
$5.38
AVG Volume (30 Days)
221.6K
67.7K
Earning Date
03-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
$22,503,908.00
Revenue This Year
N/A
$7.29
Revenue Next Year
$1.97
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.19
$0.60
52 Week High
$6.21
$1.39

Technical Indicators

Market Signals
Indicator
CMTL
CTSO
Relative Strength Index (RSI) 37.32 46.87
Support Level $2.74 $0.62
Resistance Level $6.15 $0.74
Average True Range (ATR) 0.37 0.05
MACD -0.07 -0.00
Stochastic Oscillator 3.57 18.02

Price Performance

Historical Comparison
CMTL
CTSO

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: